Mercado de tratamiento del linfedema: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00026594
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 209
Buy Now

Se prevé que el mercado del tratamiento del linfedema alcance los 11.580 millones de dólares en 2028, frente a los 8.150 millones de dólares de 2021; se espera que crezca a una tasa compuesta anual del 5,1% de 2021 a 2028.

El linfedema es una afección en la que el cuerpo se agranda anormalmente debido a la linfostasis causada por el sistema linfático. disfunción. Afecta con mayor frecuencia a la extremidad inferior (90%), la extremidad superior (10%) y los genitales (1%). El linfedema primario está presente al nacer, mientras que el linfedema secundario es causado por una ineficiencia o daño del sistema linfático. El linfedema secundario frecuentemente se desarrolla después del tratamiento del cáncer. El linfedema es causado por obstrucciones en el paso del líquido linfático causadas por cirugía, radioterapia o crecimiento del cáncer. La sensación de opresión o pesadez; hinchazón de piernas, brazos u otras partes del cuerpo; dolor o malestar; y la fibrosis, que espesa o endurece la piel, se encuentran entre los síntomas comunes del linfedema.

Perspectivas estratégicas

El crecimiento del mercado de tratamiento del linfedema se atribuye a la creciente incidencia de linfedema y al creciente número de programas de manejo del linfedema con un auge en la promoción de servicios de telesalud en varios países. Sin embargo, la falta de profesionales capacitados y los altos costos quirúrgicos en las economías en desarrollo obstaculizan el crecimiento del mercado.

regiones lucrativas en el mercado de tratamiento del linfedema

< br />

Perspectivas del mercado
Casos crecientes de linfedema

Según el Departamento de Salud y Servicios Humanos de los Estados Unidos, el linfedema puede ocurren en pacientes con cáncer al inicio de la enfermedad o después de su tratamiento, que afectan el drenaje de los ganglios linfáticos. Por ejemplo, se ha informado que puede ocurrir dentro de unos días y hasta 30 años después del tratamiento del cáncer de mama. Además, el 80% de los pacientes experimenta su inicio dentro de los tres años posteriores a la cirugía y el resto desarrolla edema a una tasa del 1% por año. Además, un gran grupo de pacientes, en particular mujeres, padece linfedema en las extremidades inferiores después del tratamiento del cáncer ginecológico, con la prevalencia más alta (37 %) entre las sobrevivientes de cáncer de vulva y la prevalencia más baja (7 %) entre las sobrevivientes de cáncer de ovario. Además, la incidencia general de linfedema del brazo oscila entre el 8% y el 56% dos años después de la cirugía. El subestudio longitudinal Alliance Z 1071 del Grupo de Oncología del Colegio Americano de Cirujanos (ACOSOG) afirma que en los ensayos de cáncer de mama, los pacientes informan una incidencia acumulada de 3 años de hinchazón y pesadez del brazo. Las opciones de tratamiento del cáncer avanzado y altamente eficaz ayudan a minimizar el riesgo de linfedema. Por lo tanto, los principales actores del mercado de terapias contra el cáncer están muy centrados en el lanzamiento de productos innovadores.

Información basada en el tipo de afección

Según el tipo de afección, El mercado mundial del tratamiento del linfedema se ha segmentado en linfedema primario y linfedema secundario. El segmento de linfedema secundario tuvo una mayor participación del mercado en 2021. Sin embargo, se prevé que el segmento de linfedema primario registre una CAGR más alta en el mercado durante el período de pronóstico. El crecimiento actual del mercado del segmento de linfedema secundario se atribuye al hecho de que el tratamiento del cáncer es una causa importante de linfedema secundario, y la mayoría de las personas que padecen linfedema secundario son altas en los países desarrollados y en desarrollo.  

Mercado de tratamiento del linfedema, por tipo de afección: 2021 y 2028


Información basada en el tipo de tratamiento

Según el tipo de tratamiento, el pronóstico global El mercado del tratamiento del linfedema se ha segmentado en terapia con láser, dispositivos y vendajes de compresión, terapia con medicamentos, procedimientos fisiológicos, procedimientos de reducción de volumen y otros. El segmento de procedimientos fisiológicos se divide además en anastomosis linfovenosa (LVA) y transferencia de ganglios linfáticos vascularizados (VLNT). Además, el segmento de procedimientos de reducción de volumen se subsegmenta en reducción de volumen quirúrgica, liposucción y otros. El segmento de dispositivos de compresión y vendajes representó la mayor cuota de mercado en 2021. Las empresas del mercado del tratamiento del linfedema están desarrollando diferentes tipos de prendas de compresión y están promocionando productos rentables. Además, se prevé que el segmento de procedimientos fisiológicos registre la CAGR más alta del mercado durante el período de pronóstico.

Información basada en el usuario final

Según el usuario final, el mercado mundial del tratamiento del linfedema se ha segmentado en hospitales, clínicas, organizaciones de investigación clínica (CRO) y otros (centros de atención ambulatoria y centros de atención primaria). El segmento de hospitales capturó la mayor participación de mercado en 2021. Se espera que el segmento de clínicas registre la CAGR más alta durante el período de pronóstico; El crecimiento del mercado de este segmento se puede atribuir al hecho de que los tratamientos para el linfedema se ofrecen principalmente en centros o unidades especializadas. Los tratamientos quirúrgicos especializados, como la liposucción y los procedimientos de reducción de volumen, se llevan a cabo en clínicas especializadas que cuentan con un departamento dedicado a la neurología o, más específicamente, al tratamiento del linfedema.

 

Los lanzamientos y aprobaciones de productos son Estrategias comúnmente adoptadas por las empresas en el mercado de tratamiento del linfedema para ampliar su huella global y carteras de productos. Además, los actores del mercado se centran en la estrategia de asociación para ampliar su clientela, lo que, a su vez, les permite mantener su marca en todo el mundo.


Perfiles de la empresa

    < li>SISTEMAS DE BIOCOMPRESIÓN
  • Táctil Médico
  • Smith & Sobrino
  • BSN medical GmbH
  • Lohmann & Rauscher GmbH & Co. KG
  • GRUPO SIGVARIS
  • ThermoTek
  • Huntleigh Healthcare Limited
  • 3M
  • Mego Afek ltd
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is Lymphedema Treatment?

Lymphedema treatment mainly refers to the treatment options that are used in combatting primary and secondary lymphedema disease conditions. Some of the treatment types that are considered in the process include laser therapy, debulking procedures, liposuction, lymph node transfer, compression, and bandaging devices.

What are the driving factors for the Lymphedema Treatment market across the NA, EU, APAC, SCAM, and MEA regions?

Key factors that are driving the growth of the market are increasing incidences of lymphedema and programs conducted by the government fuel the growth of the market.

What will be the CAGR of Lymphedema Treatment market?

The market is estimated to grow with a CAGR of 5.1% from 2021 to 2028.

Who are the key players in the Lymphedema Treatment market?

BIOCOMPRESSION SYSTEMS; Tactile Medical; Smith and Nephew; BSN Medical GmbH; Lohmann & Rauscher GmbH & Co. KG; SIGVARIS GROUP; ThermoTek; Huntleigh Healthcare Limited; 3M; Mego Afek Ltd. are among the key companies operating in the lymphedema treatment market.

The List of Companies - Lymphedema Treatment Market

  1. Biocompression Systems
  2. Essity Medical Solutions
  3. L & R Group
  4. SIGVARIS
  5. Tactile Medical
  6. SMITH + NEPHEW
  7. Thermo Tek
  8. Huntleigh Healthcare Limited.
  9. Physiopedia
  10. AIROS Medical, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports